Literature DB >> 11200094

Bioavailability of (-)-epicatechin upon intake of chocolate and cocoa in human volunteers.

S Baba1, N Osakabe, A Yasuda, M Natsume, T Takizawa, T Nakamura, J Terao.   

Abstract

We evaluated the levels of (-)-epicatechin (EC) and its metabolites in plasma and urine after intake of chocolate or cocoa by male volunteers. EC metabolites were analyzed by HPLC and LC/MS after glucuronidase and/or sulfatase treatment. The maximum levels of total EC metabolites in plasma were reached 2 hours after either chocolate or cocoa intake. Sulfate, glucuronide, and sulfoglucuronide (mixture of sulfate and glucuronide) conjugates of nonmethylated EC were the main metabolites present in plasma rather than methylated forms. Urinary excretion of total EC metabolites within 24 hours after chocolate or cocoa intake was 29.8+/-5.3%'; and 25.3+/-8.1% of total EC intake. EC in chocolate and cocoa was partly absorbed and was found to be present as a component of various conjugates in plasma, and these were rapidly excreted in urine.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11200094     DOI: 10.1080/10715760000301151

Source DB:  PubMed          Journal:  Free Radic Res        ISSN: 1029-2470


  21 in total

1.  (-)-Epicatechin prevents TNFα-induced activation of signaling cascades involved in inflammation and insulin sensitivity in 3T3-L1 adipocytes.

Authors:  Marcela A Vazquez-Prieto; Ahmed Bettaieb; Fawaz G Haj; César G Fraga; Patricia I Oteiza
Journal:  Arch Biochem Biophys       Date:  2012-03-08       Impact factor: 4.013

2.  Transport and metabolism of the tea flavonoid (-)-epicatechin by the human intestinal cell line Caco-2.

Authors:  J B Vaidyanathan; T Walle
Journal:  Pharm Res       Date:  2001-10       Impact factor: 4.200

Review 3.  Bioavailability of bioactive food compounds: a challenging journey to bioefficacy.

Authors:  Maarit J Rein; Mathieu Renouf; Cristina Cruz-Hernandez; Lucas Actis-Goretta; Sagar K Thakkar; Marcia da Silva Pinto
Journal:  Br J Clin Pharmacol       Date:  2013-03       Impact factor: 4.335

4.  Anti-inflammatory actions of (-)-epicatechin in the adipose tissue of obese mice.

Authors:  Ahmed Bettaieb; Eleonora Cremonini; Heeteak Kang; Jiye Kang; Fawaz G Haj; Patricia I Oteiza
Journal:  Int J Biochem Cell Biol       Date:  2016-08-31       Impact factor: 5.085

5.  The effect of epigallocatechin gallate on intestinal motility in mice.

Authors:  Michal Ceregrzyn; Atsukazu Kuwahara
Journal:  Environ Health Prev Med       Date:  2003-05       Impact factor: 3.674

Review 6.  Clinical pharmacokinetics of antioxidants and their impact on systemic oxidative stress.

Authors:  Edzard Schwedhelm; Renke Maas; Raphael Troost; Rainer H Böger
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 7.  Cocoa, chocolate, and cardiovascular disease.

Authors:  Monica Galleano; Patricia I Oteiza; Cesar G Fraga
Journal:  J Cardiovasc Pharmacol       Date:  2009-12       Impact factor: 3.105

Review 8.  Polyphenols from cocoa and vascular health-a critical review.

Authors:  Gerald Rimbach; Mona Melchin; Jennifer Moehring; Anika E Wagner
Journal:  Int J Mol Sci       Date:  2009-11-20       Impact factor: 6.208

Review 9.  Dietary (poly)phenolics in human health: structures, bioavailability, and evidence of protective effects against chronic diseases.

Authors:  Daniele Del Rio; Ana Rodriguez-Mateos; Jeremy P E Spencer; Massimiliano Tognolini; Gina Borges; Alan Crozier
Journal:  Antioxid Redox Signal       Date:  2012-08-27       Impact factor: 8.401

10.  Blood pressure and endothelial function in healthy, pregnant women after acute and daily consumption of flavanol-rich chocolate: a pilot, randomized controlled trial.

Authors:  Jaime Andres Mogollon; Emmanuel Bujold; Simone Lemieux; Mélodie Bourdages; Claudine Blanchet; Laurent Bazinet; Charles Couillard; Martin Noël; Sylvie Dodin
Journal:  Nutr J       Date:  2013-04-08       Impact factor: 3.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.